(Q44607835)

4 December 2017

title

Is sex associated with the outcome of patients treated with radiation for nonsmall cell lung cancer? (English)

1 reference

4 December 2017

10

Ritsuko Komaki

1 reference

4 December 2017

Susan L McGovern

1

1 reference

4 December 2017

Zhongxing Liao

2

1 reference

4 December 2017

M Kara Bucci

3

1 reference

4 December 2017

Mary Frances McAleer

4

1 reference

4 December 2017

Melenda D Jeter

5

1 reference

4 December 2017

Joe Y Chang

6

1 reference

4 December 2017

Michael S O'Reilly

7

1 reference

4 December 2017

James D Cox

8

1 reference

4 December 2017

Pamela K Allen

9

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 July 2009

1 reference

4 December 2017

1 reference

4 December 2017

volume

115

1 reference

4 December 2017

issue

14

1 reference

4 December 2017

page(s)

3233-3242

1 reference

Dose escalation of gemcitabine is possible with concurrent chest three-dimensional rather than two-dimensional radiotherapy: a phase I trial in patients with stage III non-small-cell lung cancer

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24361

21 January 2018

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24361

7 January 2021

Global cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24361

7 January 2021

Women with pathologic stage I, II, and III non-small cell lung cancer have better survival than men.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24361

7 January 2021

Sex-associated differences in presentation and survival in patients with lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24361

7 January 2021

Lung cancer in women: sex-associated differences in survival of patients undergoing resection for lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24361

7 January 2021

Menopausal effects on presentation, treatment, and survival of women with non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24361

7 January 2021

Sex differences in survival in non-small cell lung cancer patients 1974-1998

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24361

7 January 2021

Lung cancer in women: age, smoking, histology, performance status, stage, initial treatment and survival. Population-based study of 20 561 cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24361

7 January 2021

Cigarette smoking and changes in the histopathology of lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24361

7 January 2021

Sex differences in lung cancer survival: do tumors behave differently in elderly women?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24361

7 January 2021

A Japanese Lung Cancer Registry study: prognosis of 13,010 resected lung cancers.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24361

7 January 2021

Meta-analysis of disease risk associated with smoking, by gender and intensity of smoking

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24361

7 January 2021

Are female smokers at higher risk for lung cancer than male smokers? A case-control analysis by histologic type

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24361

7 January 2021

Differences in lung cancer risk between men and women: examination of the evidence.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24361

7 January 2021

Lung cancer in never smokers--a different disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24361

7 January 2021

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24361

7 January 2021

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24361

7 January 2021

Molecular predictors of response to epidermal growth factor receptor antagonists in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24361

7 January 2021

Pilot study of gefitinib and fulvestrant in the treatment of post-menopausal women with advanced non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24361

7 January 2021

Reproductive factors, hormone use, estrogen receptor expression and risk of non small-cell lung cancer in women

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24361

7 January 2021

Specific features of non-small cell lung cancer in women: a retrospective study of 1738 cases diagnosed in Bas-Rhin between 1982 and 1997

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24361

7 January 2021

Gender differences in non-small-cell lung cancer survival: an analysis of 4,618 patients diagnosed between 1997 and 2002

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24361

7 January 2021

Comparison of outcomes for patients with unresectable, locally advanced non-small-cell lung cancer treated with induction chemotherapy followed by concurrent chemoradiation vs. concurrent chemoradiation alone

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24361

7 January 2021

Do women live longer following lung resection for carcinoma?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24361

7 January 2021

Estrogen receptor signaling pathways in human non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24361

7 January 2021

Re: Endocrine factors and adenocarcinoma of the lung in women

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24361

7 January 2021

Gender differences: implications for clinical trials and practice

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24361

7 January 2021

Identifiers

DOI

10.1002/CNCR.24361

1 reference

4 December 2017

1 reference